Caliper. Through its acquisition of Xenogen, Caliper Life Sciences is now the market-leading developer of in vivo biophotonic technology, which alows real-time, non-invasive exploration of genes, proteins, pathogens, and tumor cellls in living animals.
Caliper's product lines include an impressive selection f imaging systems, biological reagents, specialized light producting animal models, and genetic modification programs for pharmaceuticals and biotechnology research and development.